ArticleTargeted oncology2017

Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.

Anna Kuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.